VESICARE Side Effects

7021880-X | Daydreaming, Dehydration, Heat Illness, Pneumonia Bacterial, Rhabdomyolysis
on Sep 17, 2010 Male patient from JAPAN , 84 years of age, was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: daydreaming, dehydration, heat illness (What is heat illness?), pneumonia bacterial, rhabdomyolysis. Vesicare dosage: 5 Mg, Oral. During the same period patient was treated with NU LOTAN (LOSARTAN POTASSIUM) PER ORAL NOS (View Nu-lotan (losartan Potassium) Per Oral Nos Review and Nu-lotan (losartan Potassium) Per Oral Nos Label ), NORVASC (View Norvasc Review and Norvasc Label ), BIOFERMIN (BACILLUS SUBTILIS, LACTOBACILLUS ACIDOPHILUS, STREPTOCOCCUS (View Biofermin (bacillus Subtilis, Lactobacillus Acidophilus, Streptococcus Review and Biofermin (bacillus Subtilis, Lactobacillus Acidophilus, Streptococcus Label ). Patient was hospitalized.

7019854-8 | Photophobia
Patient was taking Vesicare (View Usage). Patient had the following side effects: photophobia on Sep 14, 2010 from UNITED STATES Additional patient health information: Male patient , 77 years of age, was diagnosed with bladder disorder and. Vesicare dosage: 10 Mg, Total Dose, Oral ; 10 Mg, Uid/qd, Oral. During the same period patient was treated with UROXATRAL (View Uroxatral Review and Uroxatral Label ), DIOVAN (View Diovan Review and Diovan Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), UROCIT K (View Urocit-k Review and Urocit-k Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALEVE (View Aleve Review and Aleve Label ).

7019542-8 | Fluid Retention, Renal Failure
Adverse event was reported on Sep 14, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: 5 Mg, Uid/qd, Oral) was diagnosed with hypertonic bladder, urinary incontinence (What is urinary incontinence?) and. Location: UNITED STATES , weighting 172.0 lb, After Vesicare was administered, patient had the following side effects: fluid retention, renal failure. During the same period patient was treated with SYNTHROID (LEVOTHYROXIEN SODIUM) (View Synthroid (levothyroxien Sodium) Review and Synthroid (levothyroxien Sodium) Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), ZANAFLEX (View Zanaflex Review and Zanaflex Label ).

7010893-X | Aphthous Stomatitis, Dry Eye, Dry Mouth, Dyspnoea, Headache, Heart Rate Irregular, Photophobia, Pruritus
on Sep 23, 2010 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: aphthous stomatitis, dry eye, dry mouth, dyspnoea, headache (What is headache?), heart rate irregular, photophobia, pruritus. Vesicare dosage: 5 Mg 1 Daily Mouth.


7009356-7 | Blood Pressure Increased, Cerebrovascular Accident, Decreased Appetite, Diarrhoea, Disability, Heart Rate Increased, Hypoglycaemic Coma, Hypoglycaemic Encephalopathy, Incorrect Dose Administered
on Sep 15, 2010 Male patient from JAPAN , 85 years of age, weighting 121.3 lb, was diagnosed with hypertonic bladder, pollakiuria and was treated with Vesicare (View Usage). Patient had the following side effects: blood pressure increased, cerebrovascular accident, decreased appetite, diarrhoea, disability, heart rate increased, hypoglycaemic coma, hypoglycaemic encephalopathy, incorrect dose administered. Vesicare dosage: 5 Mg, Uid/qd, Oral; 10 Mg, Oral. During the same period patient was treated with FLUITRAN (TRICHLORMETHAZIDE) (View Fluitran (trichlormethazide) Review and Fluitran (trichlormethazide) Label ), SLOW K (View Slow-k Review and Slow-k Label ), BAYLOTENSIN (NITRENDIPINE) (View Baylotensin (nitrendipine) Review and Baylotensin (nitrendipine) Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), SARPOGRELATE (SARPOGRELATE) (View Sarpogrelate (sarpogrelate) Review and Sarpogrelate (sarpogrelate) Label ). Patient was hospitalized and became disabled.

7004995-1 | Fall, Haematoma, Hyponatraemia
Patient was taking Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: fall (What is fall?), haematoma, hyponatraemia on Sep 08, 2010 from SWEDEN Additional patient health information: Female patient , 76 years of age, was diagnosed with depression (What is depression?) and. Vesicare dosage: 5 Mg, Oral. During the same period patient was treated with ENALAPRIL RATIOPHARM (ENALAPRIL MALEATE) (Oral) (View Enalapril-ratiopharm (enalapril Maleate) Review and Enalapril-ratiopharm (enalapril Maleate) Label ), MINIRIN (Oral) (View Minirin Review and Minirin Label ), CITALOPRAM HYDROBROMIDE (20 Mg, Oral) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), VAGIFEM (View Vagifem Review and Vagifem Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), NEBCIN (View Nebcin Review and Nebcin Label ), NICOTINELL (NICOTINE) (View Nicotinell (nicotine) Review and Nicotinell (nicotine) Label ), CALCICHEW D3 (CALCIUM CARBONATE, COLECALCIFEROL) (View Calcichew-d3 (calcium Carbonate, Colecalciferol) Review and Calcichew-d3 (calcium Carbonate, Colecalciferol) Label ). Patient was hospitalized.

7003551-9 | Ileus
Adverse event was reported on Sep 07, 2010 by a Male patient taking Vesicare (View Usage) (Dosage: 2.5 Mg, Oral; 10 Mg, Oral; 5 Mg, Oral) was diagnosed with enuresis and. Location: JAPAN , child 9 years of age, Patient experienced the following unwanted or unexpected effects: ileus. Patient was hospitalized.

7003540-4 | Heat Illness, Pneumonia Bacterial, Rhabdomyolysis
on Sep 08, 2010 Male patient from JAPAN , 84 years of age, was treated with Vesicare (View Usage). Patient had the following side effects: heat illness (What is heat illness?), pneumonia bacterial, rhabdomyolysis. Vesicare dosage: 5 Mg, Oral. During the same period patient was treated with LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), BIOFERMIN (BACILLUS SUBTILIS, LACTOBACILLUS ACIDOPHILUS, STREPTOCOCCUS (View Biofermin (bacillus Subtilis, Lactobacillus Acidophilus, Streptococcus Review and Biofermin (bacillus Subtilis, Lactobacillus Acidophilus, Streptococcus Label ). Patient was hospitalized.

6987837-X | Abdominal Pain, Condition Aggravated, Dry Mouth, Dysgeusia, Headache, Myalgia, Oesophageal Pain, Saliva Altered
on Aug 09, 2010 Female patient from PORTUGAL , 56 years of age, weighting 216.1 lb, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), condition aggravated, dry mouth, dysgeusia, headache (What is headache?), myalgia, oesophageal pain, saliva altered. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with FLAVONID (DIOSMIN, HESPERIDIN) (View Flavonid (diosmin, Hesperidin) Review and Flavonid (diosmin, Hesperidin) Label ).

6986136-X | Rhabdomyolysis
Patient was taking Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis on Sep 02, 2010 from JAPAN Additional patient health information: Male patient , 84 years of age, . Vesicare dosage: 5 Mg, Unkown/d, Oral. During the same period patient was treated with LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), NORVASC (View Norvasc Review and Norvasc Label ), BIOFERMIN (BACILLUS SUBTILIS, LACTOBACILLUS ACIDOPHILUS, STREPTOCOCCUS (View Biofermin (bacillus Subtilis, Lactobacillus Acidophilus, Streptococcus Review and Biofermin (bacillus Subtilis, Lactobacillus Acidophilus, Streptococcus Label ). Patient was hospitalized.

6986116-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal
Adverse event was reported on Sep 01, 2010 by a Male patient taking Vesicare (View Usage) (Dosage: 5 Mg, Oral) was diagnosed with hypertonic bladder, benign prostatic hyperplasia and. Location: JAPAN , 73 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. During the same period patient was treated with FLIVAS (NAFTOPIDIL) PER ORAL NOS (50 Mg, Oral) (View Flivas (naftopidil) Per Oral Nos Review and Flivas (naftopidil) Per Oral Nos Label ), DEPAKENE (View Depakene Review and Depakene Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ). Patient was hospitalized.

6983206-7 | Escherichia Bacteraemia, Parotitis, Urinary Tract Infection
on Sep 01, 2010 Female patient from UNITED STATES , 72 years of age, was diagnosed with urinary incontinence (What is urinary incontinence?) and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: escherichia bacteraemia, parotitis, urinary tract infection (What is urinary tract infection?). Vesicare dosage: 10 Mg/d, Oral. Patient was hospitalized.

6980366-9 | Abdominal Pain, Burn Oesophageal, Dry Mouth, Dysgeusia, Headache, Myalgia, Saliva Altered, Somnolence
on Aug 09, 2010 Female patient from PORTUGAL , 56 years of age, weighting 216.1 lb, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), burn oesophageal, dry mouth, dysgeusia, headache (What is headache?), myalgia, saliva altered, somnolence. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with FLAVONID (DIOSMIN, HESPERIDIN) (View Flavonid (diosmin, Hesperidin) Review and Flavonid (diosmin, Hesperidin) Label ).

6979896-5 | Cognitive Disorder
Patient was taking Vesicare (View Usage). Patient had the following side effects: cognitive disorder on Aug 30, 2010 from JAPAN Additional patient health information: Male patient , 82 years of age, was diagnosed with hypertonic bladder and. Vesicare dosage: 2.5 Mg, Bid, Oral. During the same period patient was treated with HARNAL (TAMSULOSIN) ORODISPERSIBLE CR TABLET (View Harnal (tamsulosin) Orodispersible Cr Tablet Review and Harnal (tamsulosin) Orodispersible Cr Tablet Label ).

6973528-8 | Arthralgia, Malaise, Myalgia
Adverse event was reported on Aug 27, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: 5 Mg, Oral) was diagnosed with pollakiuria and. Location: UNITED KINGDOM , 58 years of age, After Vesicare was administered, patient had the following side effects: arthralgia, malaise, myalgia. During the same period patient was treated with INDERAL LA (View Inderal La Review and Inderal La Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6972468-8 | Constipation, Gastrointestinal Pain, Obstruction
on Sep 08, 2010 Female patient from UNITED STATES , weighting 115.0 lb, was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), gastrointestinal pain, obstruction. Vesicare dosage: 5 Mg Q12h 047 (3 Days, 1 Po The 1 @ 1-2 Days. Total 20 Tabs).

6969542-9 | Chest Discomfort, Urticaria
on Sep 07, 2010 Female patient from UNITED STATES , 49 years of age, weighting 160.0 lb, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient had the following side effects: chest discomfort, urticaria. Vesicare dosage: One Daily Po.

6964073-4 | Escherichia Infection, Pyelonephritis
Patient was taking Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: escherichia infection, pyelonephritis on Aug 20, 2010 from JAPAN Additional patient health information: Female patient , 56 years of age, weighting 158.7 lb, was diagnosed with hypertonic bladder and. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

6964069-2 | Amnesia, Cognitive Disorder, Derealisation, Flat Affect
Adverse event was reported on Jun 11, 2010 by a Male patient taking Vesicare (View Usage) (Dosage: 5 Mg, Oral) was diagnosed with urinary incontinence (What is urinary incontinence?) and. Location: SPAIN , 72 years of age, Patient experienced the following unwanted or unexpected effects: amnesia, cognitive disorder, derealisation, flat affect. During the same period patient was treated with LEXATIN (BROMAZEPAM) (View Lexatin (bromazepam) Review and Lexatin (bromazepam) Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

6963809-6 | Abdominal Pain, Burn Oesophageal, Dry Mouth, Dysgeusia, Headache, Myalgia, Saliva Altered, Somnolence
on Aug 09, 2010 Female patient from PORTUGAL , 56 years of age, weighting 216.1 lb, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), burn oesophageal, dry mouth, dysgeusia, headache (What is headache?), myalgia, saliva altered, somnolence. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with FLAVONID (DIOSMIN, HESPERIDIN) (View Flavonid (diosmin, Hesperidin) Review and Flavonid (diosmin, Hesperidin) Label ).

6947475-1 | Constipation, Gait Disturbance, Oedema Mouth, Pharyngeal Oedema, Swollen Tongue, Tooth Loss, Vision Blurred, Walking Aid User
on Aug 16, 2010 Female patient from UNITED STATES , 90 years of age, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: constipation (What is constipation?), gait disturbance, oedema mouth, pharyngeal oedema, swollen tongue, tooth loss, vision blurred, walking aid user. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with DETROL (5 Mg, Uid/qd, Oral) (View Detrol Review and Detrol Label ), FESOTERODINE (8 Mg, Uid/qd, Oral; 4 Mg, Uid/qd, Oral) (View Fesoterodine Review and Fesoterodine Label ).

6946249-5 | Back Pain, Escherichia Test Positive, Gastritis, Heart Rate Increased, Pyelonephritis, Rhinitis Allergic
Patient was taking Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), escherichia test positive, gastritis, heart rate increased, pyelonephritis, rhinitis allergic on Aug 17, 2010 from JAPAN Additional patient health information: Female patient , 56 years of age, weighting 158.7 lb, was diagnosed with hypertonic bladder and. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

6942206-3 | Neurological Symptom, Parkinson's Disease
Adverse event was reported on Aug 11, 2010 by a Male patient taking Vesicare (View Usage) (Dosage: 5 Mg, D, Oral) was diagnosed with hypertonic bladder and. Location: UNITED STATES , 87 years of age, Patient had the following side effects: neurological symptom, parkinson's disease (What is parkinson's disease?). During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), VITAMIN D NOS (VITAMIN D NOS) (View Vitamin D Nos (vitamin D Nos) Review and Vitamin D Nos (vitamin D Nos) Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ).

6932512-0 | Amnesia
on Aug 05, 2010 Male patient from UNITED STATES , 77 years of age, was diagnosed with hypertonic bladder, incontinence, micturition urgency and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: amnesia. Vesicare dosage: 10 Mg, Oral. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMINS NOS (VITAMINS NOS) (View Vitamins Nos (vitamins Nos) Review and Vitamins Nos (vitamins Nos) Label ).

6929120-4 | Blood Pressure Increased, Hypoglycaemic Coma, Incorrect Dose Administered, Movement Disorder, Oxygen Saturation Decreased, Respiratory Rate Increased
on Aug 05, 2010 Male patient from JAPAN , 85 years of age, weighting 121.3 lb, was diagnosed with hypertonic bladder, pollakiuria and was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, hypoglycaemic coma, incorrect dose administered, movement disorder (What is movement disorder?), oxygen saturation decreased, respiratory rate increased. Vesicare dosage: 5 Mg, Uid/qd, Oral; 10 Mg, Oral. During the same period patient was treated with FLUITRAN (TRICHLORMETHIAZIDE) TABLET (View Fluitran (trichlormethiazide) Tablet Review and Fluitran (trichlormethiazide) Tablet Label ), SLOW K (View Slow-k Review and Slow-k Label ), BAYLOTENSIN (NITRENDIPINE) TABLET (View Baylotensin (nitrendipine) Tablet Review and Baylotensin (nitrendipine) Tablet Label ), TRAMSULOSIN (TAMSULOSIN) CAPSULE (View Tramsulosin (tamsulosin) Capsule Review and Tramsulosin (tamsulosin) Capsule Label ), SARPOGRELATE (SARPOGRELATE) TABLET (View Sarpogrelate (sarpogrelate) Tablet Review and Sarpogrelate (sarpogrelate) Tablet Label ). Patient was hospitalized and became disabled.

6925883-2 | Blood Glucose Increased, Blood Pressure Increased, Cerebrovascular Accident, Decreased Appetite, Heart Rate Increased, Hemiplegia, Hypoglycaemic Coma, Incorrect Dose Administered
Patient was taking Vesicare (View Usage). Patient had the following side effects: blood glucose increased, blood pressure increased, cerebrovascular accident, decreased appetite, heart rate increased, hemiplegia, hypoglycaemic coma, incorrect dose administered on Aug 02, 2010 from JAPAN Additional patient health information: Male patient , 85 years of age, weighting 121.3 lb, was diagnosed with hypertonic bladder and. Vesicare dosage: 5 Mg, Oral, 5 Mg, Uid/qd, Oral, 10 Mg, Oral. During the same period patient was treated with FLUITRAN (TRICHLORMETHIAZIDE) (View Fluitran (trichlormethiazide) Review and Fluitran (trichlormethiazide) Label ), SLOW K (View Slow-k Review and Slow-k Label ), BAYLOTENSIN (NITRENDIPINE) (View Baylotensin (nitrendipine) Review and Baylotensin (nitrendipine) Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), SARPOGRELATE (SARPOGRELATE) (View Sarpogrelate (sarpogrelate) Review and Sarpogrelate (sarpogrelate) Label ), SHAKUYAKUKANZOUTOU (HERBAL EXTRACT NOS) (View Shakuyakukanzoutou (herbal Extract Nos) Review and Shakuyakukanzoutou (herbal Extract Nos) Label ). Patient was hospitalized and became disabled.

6919581-9 | Dysstasia, Hypotension, Renal Failure Acute
Adverse event was reported on Jul 28, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: 5 Mg, Uid/qd, Oral) was diagnosed with hypertonic bladder, micturition urgency and. Location: JAPAN , 77 years of age, weighting 131.4 lb, After Vesicare was administered, patient had the following side effects: dysstasia, hypotension, renal failure acute. During the same period patient was treated with LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ), LIPITOR (ATORVASTATIN CACLIUM) TABLET (View Lipitor (atorvastatin Caclium) Tablet Review and Lipitor (atorvastatin Caclium) Tablet Label ), STOGAR (LAFUTIDINE) TABLET (View Stogar (lafutidine) Tablet Review and Stogar (lafutidine) Tablet Label ), SENNOSIDE (SENNOSIDE A+B) PER ORAL NOS (View Sennoside (sennoside A+b) Per Oral Nos Review and Sennoside (sennoside A+b) Per Oral Nos Label ), BLOPRESS (CANDESARTAN CILEXETIL) TABLET (View Blopress (candesartan Cilexetil) Tablet Review and Blopress (candesartan Cilexetil) Tablet Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6915985-9 | Photophobia
on Jul 27, 2010 Male patient from UNITED STATES , 77 years of age, was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: photophobia. Vesicare dosage: 10 Mg, Total Dose, Oral; 10 Mg, Uid/qd, Oral. During the same period patient was treated with UROXATRAL (View Uroxatral Review and Uroxatral Label ).

6914756-7 | Bladder Repair, Post Procedural Haemorrhage, Postoperative Thrombosis
on Jul 26, 2010 Male patient from UNITED STATES , 79 years of age, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient had the following side effects: bladder repair, post procedural haemorrhage, postoperative thrombosis. Vesicare dosage: 5 Mg/d, Oral; 10 Mg, Uid/qd, Oral. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), GLUCOSAMIN CHONDR (CHONDROITIN SULFATE, GLUCOSAMINE SULFATE) FORMULATI (View Glucosamin Chondr (chondroitin Sulfate, Glucosamine Sulfate) Formulati Review and Glucosamin Chondr (chondroitin Sulfate, Glucosamine Sulfate) Formulati Label ). Patient was hospitalized.

6905395-2 | Chest Pain, Disorientation, Dizziness, Fatigue, Hypersomnia, Hypotension, Listless
Patient was taking Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: chest pain (What is chest pain?), disorientation, dizziness (What is dizziness?), fatigue, hypersomnia, hypotension, listless on Jul 22, 2010 from UNITED STATES Additional patient health information: Male patient , 84 years of age, was diagnosed with bladder disorder and. Vesicare dosage: 5 Mg, Qhs, Oral. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), BETA BLOCKING AGENTS (View Beta Blocking Agents Review and Beta Blocking Agents Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION (View Antihypertensives And Diuretics In Combination Review and Antihypertensives And Diuretics In Combination Label ), CELEXA (View Celexa Review and Celexa Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ). Patient was hospitalized.

6905394-0 | Neurological Symptom, Parkinson's Disease
Adverse event was reported on Jul 22, 2010 by a Male patient taking Vesicare (View Usage) (Dosage: 5 Mg, Oral) was diagnosed with hypertonic bladder and. Location: UNITED STATES , 87 years of age, Patient experienced the following unwanted or unexpected effects: neurological symptom, parkinson's disease (What is parkinson's disease?).

6902536-8 | Condition Aggravated, Decreased Appetite, Dizziness, Hypotension, Renal Failure Chronic
on Jul 22, 2010 Female patient from JAPAN , 77 years of age, weighting 131.4 lb, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient had the following side effects: condition aggravated, decreased appetite, dizziness (What is dizziness?), hypotension, renal failure chronic. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with LOSARTAN POTASSIUM W/HYDROCHLOROTHIZIDE) (HYDROCHLOROTHIAZIDE, LOSARTA (View Losartan Potassium W/hydrochlorothizide) (hydrochlorothiazide, Losarta Review and Losartan Potassium W/hydrochlorothizide) (hydrochlorothiazide, Losarta Label ), LIPITOR (View Lipitor Review and Lipitor Label ), STOGAR (LAFUTIDINE) (View Stogar (lafutidine) Review and Stogar (lafutidine) Label ), SENNOSIDE (SENNOSIDE A+B) (View Sennoside (sennoside A+b) Review and Sennoside (sennoside A+b) Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6896580-7 | Amnesia, Anxiety
on Jul 20, 2010 Female patient from CANADA , 92 years of age, was diagnosed with incontinence and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: amnesia, anxiety (What is anxiety?). Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ACTONEL (View Actonel Review and Actonel Label ).

6894829-8 | Pyelonephritis
Patient was taking Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: pyelonephritis on Jul 20, 2010 from JAPAN Additional patient health information: Female patient , 56 years of age, weighting 158.7 lb, was diagnosed with hypertonic bladder and. Vesicare dosage: 5 Mg, Uid/qd, Oral. Patient was hospitalized.

6894563-4 | Condition Aggravated, Dementia
Adverse event was reported on Jul 15, 2010 by a Female patient taking Vesicare (View Usage) (Dosage: 10 Mg, D, Oral) . Location: JAPAN , 84 years of age, Patient had the following side effects: condition aggravated, dementia (What is dementia?). During the same period patient was treated with SEROQUEL (Oral) (View Seroquel Review and Seroquel Label ), GOSHAJINKIGAN (HERBAL EXTRACT NOS) (View Goshajinkigan (herbal Extract Nos) Review and Goshajinkigan (herbal Extract Nos) Label ), YOKUKAN SAN (HERBAL EXTRACT NOS) (View Yokukan-san (herbal Extract Nos) Review and Yokukan-san (herbal Extract Nos) Label ), LENDORM (View Lendorm Review and Lendorm Label ), DESYREL (View Desyrel Review and Desyrel Label ), PROTECADIN (LAFUTIDINE) (View Protecadin (lafutidine) Review and Protecadin (lafutidine) Label ), ALOSENN (ACHILLEA MILLEFOLIUM, RUBIA TINCTORUM ROOT TINCTURE, SENNA AL (View Alosenn (achillea Millefolium, Rubia Tinctorum Root Tincture, Senna Al Review and Alosenn (achillea Millefolium, Rubia Tinctorum Root Tincture, Senna Al Label ), VITAMEDIN (BENFOTIAMINE) (View Vitamedin (benfotiamine) Review and Vitamedin (benfotiamine) Label ). Patient was hospitalized.

6882940-7 | Hypotension, Muscular Weakness
on Jun 25, 2010 Male patient from JAPAN , 78 years of age, was diagnosed with hypertonic bladder, benign prostatic hyperplasia and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: hypotension, muscular weakness. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with URIEF (SILODOSIN) TABLET (4 Mg, Uid/qd, Oral) (View Urief (silodosin) Tablet Review and Urief (silodosin) Tablet Label ).

6874591-5 | Anxiety, Bipolar Disorder, Condition Aggravated, Depression, Hypomania, Insomnia, Mood Swings
on Jul 20, 2010 Female patient from DENMARK , 29 years of age, was diagnosed with hypertonic bladder, bipolar disorder (What is bipolar disorder?) and was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), bipolar disorder (What is bipolar disorder?), condition aggravated, depression (What is depression?), hypomania, insomnia, mood swings. Vesicare dosage: 10 Mg, Uid/qd, Oral. During the same period patient was treated with ABILIFY (10 Mg, Bid, Oral) (View Abilify Review and Abilify Label ), ZOLOFT (50 Mg, Uid/qd, Oral) (View Zoloft Review and Zoloft Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), SINGULAIR (View Singulair Review and Singulair Label ), FEXOFENADINE HCL (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LYSANTIN (ORPHENADRINE HYDROCHLORIDE) (View Lysantin (orphenadrine Hydrochloride) Review and Lysantin (orphenadrine Hydrochloride) Label ), SEREVENT (View Serevent Review and Serevent Label ). Patient was hospitalized.

6869775-6 | Localised Oedema, Oedema Peripheral
Patient was taking Vesicare (View Usage). Patient had the following side effects: localised oedema, oedema peripheral on Jul 12, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 56 years of age, weighting 130.1 lb, was diagnosed with micturition urgency and. Vesicare dosage: .

6866005-6 | Blood Sodium Decreased, Dizziness, Electrocardiogram Qt Prolonged, Hypotension
Adverse event was reported on Jul 09, 2010 by a Male patient taking Vesicare (View Usage) (Dosage: 5 Mg, /d) was diagnosed with essential hypertension and. Location: SWEDEN , 68 years of age, After Vesicare was administered, patient had the following side effects: blood sodium decreased, dizziness (What is dizziness?), electrocardiogram qt prolonged, hypotension. During the same period patient was treated with METOPROLOL SUCCINATE (200 Mg, /d) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ENALAPRIL MALEATE (10 Mg, /d, Oral) (View Enalapril Maleate Review and Enalapril Maleate Label ), ALFUZOSIN (ALFUZOSIN) (10 Mg, /d, Oral) (View Alfuzosin (alfuzosin) Review and Alfuzosin (alfuzosin) Label ). Patient was hospitalized.

6865818-4 | Apallic Syndrome, Hypoglycaemic Coma
on Jul 12, 2010 Male patient from JAPAN , 85 years of age, was diagnosed with hypertonic bladder, nocturia and was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: apallic syndrome, hypoglycaemic coma. Vesicare dosage: See Image. During the same period patient was treated with FLUITRAN (TRICHLORMETHIAZIDE) TABLET (View Fluitran (trichlormethiazide) Tablet Review and Fluitran (trichlormethiazide) Tablet Label ), SLOW K (View Slow-k Review and Slow-k Label ), BAYLOTENSIN (NITRENDIPINE) (View Baylotensin (nitrendipine) Review and Baylotensin (nitrendipine) Label ).

6862390-X | Platelet Count Decreased
on Jul 07, 2010 Female patient from JAPAN , 31 years of age, weighting 112.4 lb, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient had the following side effects: platelet count decreased. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with BIOFERMIN (BACILLUS SUBTILIS, LACTOBACILLUS, ACIDOPHILUS, STREPTOCOCCU (View Biofermin (bacillus Subtilis, Lactobacillus, Acidophilus, Streptococcu Review and Biofermin (bacillus Subtilis, Lactobacillus, Acidophilus, Streptococcu Label ).

6859447-6 | Intraocular Pressure Increased, Mydriasis, Overdose, Pupillary Reflex Impaired, Treatment Failure, Vision Blurred
Patient was taking Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: intraocular pressure increased, mydriasis, overdose, pupillary reflex impaired, treatment failure, vision blurred on Jul 06, 2010 from UNITED STATES Additional patient health information: Female patient , 56 years of age, . Vesicare dosage: 5 Mg, /d, Oral ; 20 Mg, /d, Oral ; Oral. During the same period patient was treated with PROSTAGLANDINS (View Prostaglandins Review and Prostaglandins Label ), ALPHA 2 AGONIST (View Alpha-2 Agonist Review and Alpha-2 Agonist Label ), NEURONTIN (View Neurontin Review and Neurontin Label ).

6846592-4 | Bladder Repair, Haemorrhage, Thrombosis
Adverse event was reported on Jul 01, 2010 by a Male patient taking Vesicare (View Usage) (Dosage: 5 Mg, /d, Oral; 10 Mg, /d, Oral) was diagnosed with hypertonic bladder and. Location: UNITED STATES , 79 years of age, Patient experienced the following unwanted or unexpected effects: bladder repair, haemorrhage, thrombosis. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), GLUCOSAMIN CHONDR (CHONDROITIN SULFATE, GLUCOSAMINE SULFATE) (View Glucosamin Chondr (chondroitin Sulfate, Glucosamine Sulfate) Review and Glucosamin Chondr (chondroitin Sulfate, Glucosamine Sulfate) Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ACTOS (View Actos Review and Actos Label ), GLIBEZIDE (GLIBEZIDE) (View Glibezide (glibezide) Review and Glibezide (glibezide) Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ZETIA (View Zetia Review and Zetia Label ). Patient was hospitalized.

6846578-X | Asthenia, Blood Sodium Decreased, Nocturia
on Jul 01, 2010 Male patient from UNITED STATES , 75 years of age, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient had the following side effects: asthenia, blood sodium decreased, nocturia. Vesicare dosage: 10 Mg, Uqd/qd, Oral. During the same period patient was treated with DESMOPRESSION (DESMOPRESSION) (View Desmopression (desmopression) Review and Desmopression (desmopression) Label ). Patient was hospitalized.

6839766-X | Platelet Count Decreased
on Jun 29, 2010 Female patient from JAPAN , 31 years of age, weighting 112.4 lb, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: platelet count decreased. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with BIOFERMIN (BACILLUS SUBTILIS, LACTOBACILLUS ACIDOPHILUS, STREPTOCOCCUS (View Biofermin (bacillus Subtilis, Lactobacillus Acidophilus, Streptococcus Review and Biofermin (bacillus Subtilis, Lactobacillus Acidophilus, Streptococcus Label ).

6839748-8 | Myelodysplastic Syndrome
Patient was taking Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: myelodysplastic syndrome on Jun 30, 2010 from JAPAN Additional patient health information: Female patient , 80 years of age, weighting 119.7 lb, was diagnosed with hypertonic bladder and. Vesicare dosage: 5 Mg, Uid/qd, Oral. During the same period patient was treated with BONALON (ALENDRONATE SODIUM) PER ORAL NOS. 35 MG (View Bonalon (alendronate Sodium) Per Oral Nos. 35 Mg Review and Bonalon (alendronate Sodium) Per Oral Nos. 35 Mg Label ), ONEALFA (ALFACALCIDOL) TABLET, 1 UG (View Onealfa (alfacalcidol) Tablet, 1 Ug Review and Onealfa (alfacalcidol) Tablet, 1 Ug Label ), MOBIC (MELOXICAM) PER ORAL NOS, 10 MG (View Mobic (meloxicam) Per Oral Nos, 10 Mg Review and Mobic (meloxicam) Per Oral Nos, 10 Mg Label ), GASLON N (IRSOGLADINE MALEATE) ORODISPERSIBLE CR TABLET, 2 MG (View Gaslon N (irsogladine Maleate) Orodispersible Cr Tablet, 2 Mg Review and Gaslon N (irsogladine Maleate) Orodispersible Cr Tablet, 2 Mg Label ), SHAKUYAKUKANZOUTOU (HERBAL EXTRACT NOS) PER ORAL NOS (View Shakuyakukanzoutou (herbal Extract Nos) Per Oral Nos Review and Shakuyakukanzoutou (herbal Extract Nos) Per Oral Nos Label ), OPALMON (LIMAPROST) PER ORAL NOS, 5 UG (View Opalmon (limaprost) Per Oral Nos, 5 Ug Review and Opalmon (limaprost) Per Oral Nos, 5 Ug Label ).

6816883-1 | Hypotension, Muscular Weakness
Adverse event was reported on Jun 21, 2010 by a Male patient taking Vesicare (View Usage) (Dosage: 5 Mg, Uid/qd, Oral) was diagnosed with hypertonic bladder, benign prostatic hyperplasia and. Location: JAPAN , 78 years of age, Patient had the following side effects: hypotension, muscular weakness. During the same period patient was treated with URIEF (SILODOSIN) TABLET (4 Mg, Uid/qd, Oral) (View Urief (silodosin) Tablet Review and Urief (silodosin) Tablet Label ).

6816451-1 | Abdominal Pain Upper, Bladder Cyst, Hysterectomy
on Jun 18, 2010 Female patient from UNITED STATES , 66 years of age, was diagnosed with pollakiuria and was treated with Vesicare (View Usage). After Vesicare was administered, patient had the following side effects: abdominal pain upper, bladder cyst, hysterectomy (What is hysterectomy?). Vesicare dosage: 10 Mg, Uid/qd, Oral. During the same period patient was treated with ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), EXFORGE (View Exforge Review and Exforge Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6816252-4 | Asthenia, Blood Sodium Decreased
on Jun 21, 2010 Male patient from UNITED STATES , 75 years of age, was diagnosed with hypertonic bladder and was treated with Vesicare (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood sodium decreased. Vesicare dosage: 10 Mg, D, Oral. During the same period patient was treated with DESMOPRESSIN ACETATE (View Desmopressin Acetate Review and Desmopressin Acetate Label ). Patient was hospitalized.

6811350-3 | Abdominal Discomfort, Constipation, Cough, Diarrhoea, Dizziness, Dry Mouth, Eye Irritation, Fatigue, Headache
Patient was taking Vesicare (View Usage). Patient had the following side effects: abdominal discomfort, constipation (What is constipation?), cough, diarrhoea, dizziness (What is dizziness?), dry mouth, eye irritation, fatigue, headache (What is headache?) on Jun 29, 2010 from UNITED STATES Additional patient health information: Female patient , 86 years of age, weighting 112.0 lb, was diagnosed with bladder disorder and. Vesicare dosage: One Pill Once A Day Mouth.